{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T06:08:54Z","timestamp":1789538934310,"version":"build-2803163510"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2024,5,4]],"date-time":"2024-05-04T00:00:00Z","timestamp":1714780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,5,4]],"date-time":"2024-05-04T00:00:00Z","timestamp":1714780800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1007\/s00415-024-12382-5","type":"journal-article","created":{"date-parts":[[2024,5,4]],"date-time":"2024-05-04T09:01:40Z","timestamp":1714813300000},"page":"4503-4512","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Correlation between severe attacks and serum aquaporin-4 antibody titer in neuromyelitis optica spectrum disorder"],"prefix":"10.1007","volume":"271","author":[{"given":"Rui","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongren","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyan","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingyao","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongxi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenqin","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nana","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7637-1305","authenticated-orcid":false,"given":"Hongyu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,5,4]]},"reference":[{"issue":"2","key":"12382_CR1","doi-asserted-by":"publisher","first-page":"e177","DOI":"10.1212\/WNL.0000000000001729","volume":"85","author":"DM Wingerchuk","year":"2015","unstructured":"Wingerchuk DM, Banwell B, Bennett JL et al (2015) International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology 85(2):e177\u2013e189. https:\/\/doi.org\/10.1212\/WNL.0000000000001729","journal-title":"Neurology"},{"issue":"14","key":"12382_CR2","doi-asserted-by":"publisher","first-page":"e1197","DOI":"10.1212\/WNL.0b013e3182a6cb5c","volume":"81","author":"Y Jiao","year":"2013","unstructured":"Jiao Y, Fryer JP, Lennon VA et al (2013) Updated estimate of AQP4-IgG serostatus and disability outcome in neuromyelitis optica. Neurology 81(14):e1197\u2013e1204. https:\/\/doi.org\/10.1212\/WNL.0b013e3182a6cb5c","journal-title":"Neurology"},{"issue":"5","key":"12382_CR3","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1093\/brain\/awm047","volume":"130","author":"T Misu","year":"2007","unstructured":"Misu T, Fujihara K, Kakita A et al (2007) Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis. Brain 130(5):1224\u20131234. https:\/\/doi.org\/10.1093\/brain\/awm047","journal-title":"Brain"},{"issue":"5","key":"12382_CR4","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1093\/brain\/awl371","volume":"130","author":"SF Roemer","year":"2007","unstructured":"Roemer SF, Parisi JE, Lennon VA et al (2007) Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis. Brain 130(5):1194\u20131205. https:\/\/doi.org\/10.1093\/brain\/awl371","journal-title":"Brain"},{"key":"12382_CR5","doi-asserted-by":"publisher","first-page":"577387","DOI":"10.1016\/j.jneuroim.2020.577387","volume":"348","author":"X Ma","year":"2020","unstructured":"Ma X, Kermode AG, Hu X et al (2020) NMOSD acute attacks: understanding, treatment, and innovative treatment prospects. J Neuroimmunol 348:577387. https:\/\/doi.org\/10.1016\/j.jneuroim.2020.577387","journal-title":"J Neuroimmunol"},{"issue":"4","key":"12382_CR6","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1136\/jnnp-2017-316286","volume":"89","author":"M Bonnan","year":"2018","unstructured":"Bonnan M, Valentino R, Debeugny S et al (2018) Short delay into initiate plasma exchange is the strongest predictor of outcome in severe attacks of NMO spectrum disorders. J Neurosurg Psychiatry 89(4):346\u2013351. https:\/\/doi.org\/10.1136\/jnnp-2017-316286","journal-title":"J Neurosurg Psychiatry"},{"key":"12382_CR7","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/1742-2094-9-14","volume":"9","author":"S Jarius","year":"2012","unstructured":"Jarius S, Ruprecht K, Wildemann B et al (2012) Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: a multicentre study of 175 patients. J Neuroinflammation 9:14. https:\/\/doi.org\/10.1186\/1742-2094-9-14","journal-title":"J Neuroinflammation"},{"key":"12382_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2021.577494","volume":"353","author":"Q Du","year":"2021","unstructured":"Du Q, Shi Z, Chen H et al (2021) Comparison of clinical characteristics and prognoses in patients with different AQP4-Ab and MOG-Ab serostatuses with neuromyelitis optica spectrum disorders. J Neuroimmunol 353:577494. https:\/\/doi.org\/10.1016\/j.jneuroim.2021.577494","journal-title":"J Neuroimmunol"},{"issue":"11","key":"12382_CR9","doi-asserted-by":"publisher","first-page":"3072","DOI":"10.1093\/brain\/awn240","volume":"131","author":"S Jarius","year":"2008","unstructured":"Jarius S, Aboul-Enein F, Waters P et al (2008) Antibody to aquaporin-4 in the long-term course of neuromyelitis optica. Brain 131(11):3072\u20133080. https:\/\/doi.org\/10.1093\/brain\/awn240","journal-title":"Brain"},{"issue":"5","key":"12382_CR10","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1093\/brain\/awm062","volume":"130","author":"T Takahashi","year":"2007","unstructured":"Takahashi T, Fujihara K, Nakashima I et al (2007) Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: a study on antibody titre. Brain 130(5):1235\u20131243. https:\/\/doi.org\/10.1093\/brain\/awm062","journal-title":"Brain"},{"issue":"8","key":"12382_CR11","doi-asserted-by":"publisher","first-page":"708","DOI":"10.3969\/j.issn.1673-5374.2013.08.005","volume":"8","author":"M Li","year":"2013","unstructured":"Li M, Su W, Wang J et al (2013) Detection of anti-aquaporin-4 autoantibodies in the sera of Chinese neuromyelitis optica patients. Neural Regen Res 8(8):708\u2013713. https:\/\/doi.org\/10.3969\/j.issn.1673-5374.2013.08.005","journal-title":"Neural Regen Res"},{"issue":"21","key":"12382_CR12","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.3760\/cma.j.issn.0376-2491.2018.21.008","volume":"98","author":"X Huang","year":"2018","unstructured":"Huang X, Xu FF, Qian HR et al (2018) Clinical presentations of neuromyelitis optica spectrum disorders with ultra-longitudinally extensive transverse myelitis. Eur PMC 98(21):1658\u20131663. https:\/\/doi.org\/10.3760\/cma.j.issn.0376-2491.2018.21.008","journal-title":"Eur PMC"},{"key":"12382_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2020.577168","volume":"340","author":"T Akaishi","year":"2020","unstructured":"Akaishi T, Takahashi T, Himori N et al (2020) Serum AQP4-IgG level is associated with the phenotype of the first attack in neuromyelitis optica spectrum disorders. J Neuroimmunol 340:577168. https:\/\/doi.org\/10.1016\/j.jneuroim.2020.577168","journal-title":"J Neuroimmunol"},{"key":"12382_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2020.116671","volume":"410","author":"T Akaishi","year":"2020","unstructured":"Akaishi T, Takahashi T, Nakashima I et al (2020) Repeated follow-up of AQP4-IgG titer by cell-based assay in neuromyelitis optica spectrum disorders (NMOSD). J Neurol Sci 410:116671. https:\/\/doi.org\/10.1016\/j.jns.2020.116671","journal-title":"J Neurol Sci"},{"key":"12382_CR15","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.msard.2017.08.005","volume":"17","author":"RA Kessler","year":"2017","unstructured":"Kessler RA, Mealy MA, Jimenez-Arango JA et al (2017) Anti-aquaporin-4 titer is not predictive of disease course in neuromyelitis optica spectrum disorder: a multicenter cohort study. Multi Scler Relat Disorder 17:198\u2013201. https:\/\/doi.org\/10.1016\/j.msard.2017.08.005","journal-title":"Multi Scler Relat Disorder"},{"key":"12382_CR16","doi-asserted-by":"publisher","first-page":"635419","DOI":"10.3389\/fneur.2021.635419","volume":"12","author":"O Schmetzer","year":"2021","unstructured":"Schmetzer O, Lakin E, Roediger B et al (2021) Anti-aquaporin 4 IgG is not associated with any clinical disease characteristics in neuromyelitis optica spectrum disorder. Front Neurol 12:635419. https:\/\/doi.org\/10.3389\/fneur.2021.635419","journal-title":"Front Neurol"},{"issue":"10","key":"12382_CR17","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1212\/01.wnl.0000216139.44259.74","volume":"66","author":"DM Wingerchuk","year":"2006","unstructured":"Wingerchuk DM, Lennon VA, Pittock SJ et al (2006) Revised diagnostic criteria for neuromyelitis optica. Neurology 66(10):1485\u20131489. https:\/\/doi.org\/10.1212\/01.wnl.0000216139.44259.74","journal-title":"Neurology"},{"key":"12382_CR18","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.jns.2010.01.002","volume":"291","author":"S Jarius","year":"2010","unstructured":"Jarius S, Probst C, Borowski K et al (2010) A standardized method for detecting antibodies against aquaporin-4 is based on a highly sensitive immunofluorescence assay employing a recombinant target antigen. J Neurol Sci 291:52\u201356. https:\/\/doi.org\/10.1016\/j.jns.2010.01.002","journal-title":"J Neurol Sci"},{"issue":"6","key":"12382_CR19","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1002\/ana.26623","volume":"93","author":"HX Yin","year":"2023","unstructured":"Yin HX, Wang YJ, Liu MG et al (2023) Aquaporin-4 antibody dynamics and relapse risk in seropositive neuromyelitis optica spectrum disorder treated with immunosuppressants. Ann Neurol 93(6):1069\u20131081. https:\/\/doi.org\/10.1002\/ana.26623","journal-title":"Ann Neurol"},{"issue":"1","key":"12382_CR20","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1111\/ene.13186","volume":"24","author":"H Chen","year":"2016","unstructured":"Chen H, Qiu W, Zhang Q et al (2016) Comparison of the efficacy and tolerability of mycophenolate mofetil and azathioprine as treatments for neuromyelitis optica and neuromyelitis optica spectrum disorder. Eur J Neurol 24(1):219\u2013226. https:\/\/doi.org\/10.1111\/ene.13186","journal-title":"Eur J Neurol"},{"key":"12382_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2023.578151","volume":"382","author":"R Wang","year":"2023","unstructured":"Wang R, Sun DR, Du Q et al (2023) Serum antinuclear antibodies associate with severe disease activity in neuromyelitis optica spectrum disorder. J Neuroimmunol 382:578151. https:\/\/doi.org\/10.1016\/j.jneuroim.2023.578151","journal-title":"J Neuroimmunol"},{"issue":"1","key":"12382_CR22","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.jocn.2012.06.006","volume":"20","author":"Y Yang","year":"2013","unstructured":"Yang Y, Huang DH, Wu WP et al (2013) The role of aquaporin-4 antibodies in Chinese patients with neuromyelitis optica. J Clin Neurosci 20(1):94\u201398. https:\/\/doi.org\/10.1016\/j.jocn.2012.06.006","journal-title":"J Clin Neurosci"},{"issue":"5","key":"12382_CR23","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1093\/brain\/awz054","volume":"142","author":"J Palace","year":"2019","unstructured":"Palace J, Lin DY, Zeng D et al (2019) Outcome prediction models in AQP4-IgG positive neuromyelitis optica spectrum disorders. Brain 142(5):1310\u20131323. https:\/\/doi.org\/10.1093\/brain\/awz054","journal-title":"Brain"},{"issue":"14","key":"12382_CR24","doi-asserted-by":"publisher","first-page":"1209323","DOI":"10.3389\/fimmu.2023.1209323","volume":"2023","author":"W Luo","year":"2023","unstructured":"Luo W, Kong L, Chen H et al (2023) Visual disability in neuromyelitis optica spectrum disorders: prognostic prediction models. Front Immunol 2023(14):1209323. https:\/\/doi.org\/10.3389\/fimmu.2023.1209323","journal-title":"Front Immunol"},{"key":"12382_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.746959","volume":"12","author":"J Liu","year":"2021","unstructured":"Liu J, Tan G, Li B et al (2021) Serum Aquaporin 4-immunoglobulin G titer and neuromyelitis optica spectrum disorder activity and severity: a systematic review and meta-analysis. Front Neurol 12:746959. https:\/\/doi.org\/10.3389\/fneur.2021.746959","journal-title":"Front Neurol"},{"issue":"11","key":"12382_CR26","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1177\/1352458512443917","volume":"18","author":"N Isobe","year":"2012","unstructured":"Isobe N, Yonekawa T, Matsushita T et al (2012) Quantitative assays for anti-aquaporin-4 antibody with subclass analysis in neuromyelitis optica. Mult Scler (Houndmills, Basingstoke, England) 18(11):1541\u20131551. https:\/\/doi.org\/10.1177\/1352458512443917","journal-title":"Mult Scler (Houndmills, Basingstoke, England)"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-024-12382-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-024-12382-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-024-12382-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T10:39:36Z","timestamp":1720521576000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-024-12382-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,4]]},"references-count":26,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["12382"],"URL":"https:\/\/doi.org\/10.1007\/s00415-024-12382-5","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,4]]},"assertion":[{"value":"22 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None of the authors have any conflicts of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"This study was approved by the Medical Ethics Committee of the West China Hospital, Sichuan University. Patients provided written informed consent to participate in this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}